PMC:7161517 / 19354-19551 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T115","span":{"begin":133,"end":137},"obj":"Body_part"}],"attributes":[{"id":"A115","pred":"fma_id","subj":"T115","obj":"http://purl.org/sig/ont/fma/fma12520"}],"text":"Overall, because of the demonstrated anti-inflammatory, antifibrotic, and antithrombotic effects associated with the ACE2/Ang1-7/Mas axis, upregulation could serve as a valuable therapeutic target."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T187","span":{"begin":167,"end":168},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Overall, because of the demonstrated anti-inflammatory, antifibrotic, and antithrombotic effects associated with the ACE2/Ang1-7/Mas axis, upregulation could serve as a valuable therapeutic target."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T122","span":{"begin":0,"end":197},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Overall, because of the demonstrated anti-inflammatory, antifibrotic, and antithrombotic effects associated with the ACE2/Ang1-7/Mas axis, upregulation could serve as a valuable therapeutic target."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T712","span":{"begin":74,"end":88},"obj":"GO:0007596"},{"id":"T713","span":{"begin":117,"end":121},"obj":"G_3;PG_10;PR:000003622"},{"id":"T714","span":{"begin":122,"end":126},"obj":"PR:000036013"},{"id":"T715","span":{"begin":129,"end":132},"obj":"PR:000001563"},{"id":"T44915","span":{"begin":33,"end":38},"obj":"SP_6;NCBITaxon:9606;PG_10"},{"id":"T17920","span":{"begin":39,"end":70},"obj":"PG_10;PR:000003622"}],"text":"Overall, because of the demonstrated anti-inflammatory, antifibrotic, and antithrombotic effects associated with the ACE2/Ang1-7/Mas axis, upregulation could serve as a valuable therapeutic target."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"840","span":{"begin":117,"end":121},"obj":"Gene"},{"id":"841","span":{"begin":122,"end":128},"obj":"Gene"}],"attributes":[{"id":"A840","pred":"tao:has_database_id","subj":"840","obj":"Gene:59272"},{"id":"A841","pred":"tao:has_database_id","subj":"841","obj":"Gene:284"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Overall, because of the demonstrated anti-inflammatory, antifibrotic, and antithrombotic effects associated with the ACE2/Ang1-7/Mas axis, upregulation could serve as a valuable therapeutic target."}